...in a series C round led by SoftBank Vision Fund. New investors Goldman Sachs and Hanwha...

...the oncology exodus. He then spent two years as head of the biobusiness unit at Hanwha...
...Sang Hoon Lee also has founded a new company, following a stint as head of Hanwha...
...investors. While Lee did not spend time at LG, his experience at Western biotechs and Hanwha...

.../ Biogen Inc. (NASDAQ:BIIB) / Merck & Co. Inc. (NYSE:MRK) Mkt in EU, South Korea Hanwha...

...and certain Caribbean and Latin American countries. CHS-0214 entered Phase III testing in July 2014. Hanwha...
...Mass. Coherus BioSciences Inc. (NASDAQ:CHRS), Redwood City, Calif. European Medicines Agency (EMA) , London, U.K. Hanwha...

...Pasteur Institute, the provincial government of Gyeonggi-do, and venture investors Atinum Investment Co. Ltd. , Hanwha...
...Ltd. (KOSDAQ:021080), Seoul, South Korea Global Alliance for TB Drug Development , New York, N.Y. Hanwha...

...with co-manager Hanwha Investment Corp., the VC arm of conglomerate Hanwha Group . Oxford and Hanwha...

...Investment. The private placement was with Korea Seoul Life Sciences Fund (KSLSF), whose GPs are Hanwha...

...Holdings Corp. , which announced a partnership in November, and Merck & Co. Inc. and Hanwha...
...NYSE:BAX), Deerfield, Ill. Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Fujifilm Holdings Corp. (Tokyo:4901), Tokyo, Japan Hanwha...

...& Co. Inc. (NYSE:MRK, Whitehouse Station, N.J.) is developing a biosimilar version of etanercept with Hanwha...

...biosimilar challenge. Merck & Co. Inc. (NYSE:MRK) is developing a biosimilar version of etanercept with Hanwha...